We have observed significantly higher BAFF levels in patients with AChRAb(+) MG in comparison with MuSK-MG, although, as in previous reports, our MuSK-MG group was small (Guptill et al. 2015; Ragheb et al. 2008). This evidence concerns the gene TNFSF13B and myasthenia gravis.